PRIMAXIN
These highlights do not include all the information needed to use PRIMAXIN safely and effectively. See full prescribing information for PRIMAXIN. PRIMAXIN® (imipenem and cilastatin) for Injection, for intravenous useInitial U.S. Approval: 1985
f41d8abd-7792-4918-1b93-bd83ea01955e
HUMAN PRESCRIPTION DRUG LABEL
Dec 1, 2023
Merck Sharp & Dohme LLC
DUNS: 118446553
Products 4
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
imipenem and cilastatin sodium
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (3)
imipenem and cilastatin sodium
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (3)
imipenem and cilastatin sodium
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (3)
imipenem and cilastatin sodium
Product Details
FDA regulatory identification and product classification information